| Literature DB >> 24486104 |
Yuyu Niu1, Bin Shen2, Yiqiang Cui3, Yongchang Chen1, Jianying Wang2, Lei Wang3, Yu Kang1, Xiaoyang Zhao4, Wei Si1, Wei Li4, Andy Peng Xiang5, Jiankui Zhou2, Xuejiang Guo3, Ye Bi3, Chenyang Si1, Bian Hu2, Guoying Dong3, Hong Wang1, Zuomin Zhou3, Tianqing Li1, Tao Tan1, Xiuqiong Pu1, Fang Wang1, Shaohui Ji1, Qi Zhou4, Xingxu Huang6, Weizhi Ji7, Jiahao Sha8.
Abstract
Monkeys serve as important model species for studying human diseases and developing therapeutic strategies, yet the application of monkeys in biomedical researches has been significantly hindered by the difficulties in producing animals genetically modified at the desired target sites. Here, we first applied the CRISPR/Cas9 system, a versatile tool for editing the genes of different organisms, to target monkey genomes. By coinjection of Cas9 mRNA and sgRNAs into one-cell-stage embryos, we successfully achieve precise gene targeting in cynomolgus monkeys. We also show that this system enables simultaneous disruption of two target genes (Ppar-γ and Rag1) in one step, and no off-target mutagenesis was detected by comprehensive analysis. Thus, coinjection of one-cell-stage embryos with Cas9 mRNA and sgRNAs is an efficient and reliable approach for gene-modified cynomolgus monkey generation.Entities:
Mesh:
Year: 2014 PMID: 24486104 DOI: 10.1016/j.cell.2014.01.027
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582